Neuroendocrine differentiation markers, such as insulinoma‐associated protein‐1 (INSM1), encoded by the insulinoma‐associated protein‐1 gene, can promote breast cancer development by regulating C‐MYC [19]. Here, MYC is linked to breast carcinoma.